Order Article Reprints

Vrachatis DA, Papathanasiou KA, Giotaki SG, Raisakis K, Kossyvakis C, Kaoukis A, Kolokathis F, Deftereos G, Iliodromitis KE, Avramides D, et al. Immunologic Dysregulation and Hypercoagulability as a Pathophysiologic Background in COVID-19 Infection and the Immunomodulating Role of Colchicine. Journal of Clinical Medicine. 2021; 10(21):5128. https://doi.org/10.3390/jcm10215128

Vrachatis, Dimitrios A., Konstantinos A. Papathanasiou, Sotiria G. Giotaki, Konstantinos Raisakis, Charalampos Kossyvakis, Andreas Kaoukis, Fotis Kolokathis, Gerasimos Deftereos, Konstantinos E. Iliodromitis, Dimitrios Avramides, and et al. 2021. "Immunologic Dysregulation and Hypercoagulability as a Pathophysiologic Background in COVID-19 Infection and the Immunomodulating Role of Colchicine" Journal of Clinical Medicine 10, no. 21: 5128. https://doi.org/10.3390/jcm10215128

Vrachatis, D. A., Papathanasiou, K. A., Giotaki, S. G., Raisakis, K., Kossyvakis, C., Kaoukis, A., Kolokathis, F., Deftereos, G., Iliodromitis, K. E., Avramides, D., Bogossian, H., Siasos, G., Giannopoulos, G., Reimers, B., Lansky, A., Tardif, J.-C., & Deftereos, S. (2021). Immunologic Dysregulation and Hypercoagulability as a Pathophysiologic Background in COVID-19 Infection and the Immunomodulating Role of Colchicine. Journal of Clinical Medicine, 10(21), 5128. https://doi.org/10.3390/jcm10215128